A University at Buffalo psychologist has received a $3.2 million grant from the National Cancer Institute to assess how cannabis use affects patients who receive immunotherapy. Thomas Jefferson University and Oregon Health and Science University will join UB in recruiting participants for the three-site, 12-month observational study to advance the science regarding the benefits and harms of cannabis use over time among those cancer patients treated with immunotherapy.  Read the article here.